The medical landscape for blood sugar is changing, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike subcutaneous injections, this method offers a more convenient way to provide GLP-1 medications. These transdermal systems steadily release the drug through the skin offering a stable level of the beneficial agent, … Read More